These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 9844478

  • 1. [Prevention and treatment of infections in patients with neutropenia and fever: the role of Pseudomonas aeruginosa].
    Jiménez Martínez C, Ribera Santasusana JM, Giménez Pérez M, Batlle Masana M, Flores López A, Fernández-Avilés F, Sancho Cía JM, Millá Santos F, Feliu Frasnedo E.
    Rev Clin Esp; 1998 Sep; 198 Suppl 2():44-50. PubMed ID: 9844478
    [No Abstract] [Full Text] [Related]

  • 2. Pseudomonas aeruginosa infection in cystic fibrosis: prevent, eradicate or both?
    Eber E, Zach MS.
    Thorax; 2010 Oct; 65(10):849-51. PubMed ID: 20861286
    [No Abstract] [Full Text] [Related]

  • 3. Antimicrobial prophylaxis in febrile neutropenia.
    Yoshida M, Ohno R.
    Clin Infect Dis; 2004 Jul 15; 39 Suppl 1():S65-7. PubMed ID: 15250025
    [Abstract] [Full Text] [Related]

  • 4. [Neutropenia and opportunistic infection].
    Ono Y.
    Nihon Rinsho; 2003 Mar 15; 61 Suppl 3():127-33. PubMed ID: 12717959
    [No Abstract] [Full Text] [Related]

  • 5. Antibacterial prophylaxis in patients with cancer and neutropenia.
    Almyroudis NG, Segal BH.
    N Engl J Med; 2006 Jan 05; 354(1):90-4; author reply 90-4. PubMed ID: 16395832
    [No Abstract] [Full Text] [Related]

  • 6. Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary.
    Masaoka T.
    Clin Infect Dis; 2004 Jul 15; 39 Suppl 1():S49-52. PubMed ID: 15250021
    [No Abstract] [Full Text] [Related]

  • 7. Unusual presentation of pseudomonas infection.
    Weinbren MJ, Forgeson G, Helenglass G, Jameson B, Powles R.
    BMJ; 1988 Oct 22; 297(6655):1034-5. PubMed ID: 3142602
    [No Abstract] [Full Text] [Related]

  • 8. Prophylactic antibiotics in cystic fibrosis: a conviction without evidence?
    Smyth A.
    Pediatr Pulmonol; 2005 Dec 22; 40(6):471-6. PubMed ID: 16200640
    [Abstract] [Full Text] [Related]

  • 9. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens.
    Ramphal R.
    Clin Infect Dis; 2004 Jul 15; 39 Suppl 1():S25-31. PubMed ID: 15250017
    [Abstract] [Full Text] [Related]

  • 10. Synthetic peptide vaccine and antibody therapeutic development: prevention and treatment of Pseudomonas aeruginosa.
    Cachia PJ, Hodges RS.
    Biopolymers; 2003 Jul 15; 71(2):141-68. PubMed ID: 12767116
    [Abstract] [Full Text] [Related]

  • 11. Treatment of patients with hematologic neoplasm, fever, and neutropenia.
    Sepkowitz KA.
    Clin Infect Dis; 2005 Apr 01; 40 Suppl 4():S253-6. PubMed ID: 15768331
    [Abstract] [Full Text] [Related]

  • 12. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
    Lai Z, Kimmel R, Petersen S, Thomas S, Pier G, Bezabeh B, Luo R, Schreiber JR.
    Vaccine; 2005 May 09; 23(25):3264-71. PubMed ID: 15837231
    [Abstract] [Full Text] [Related]

  • 13. Antibiotics in 30 minutes or less for febrile neutropenic patients: a quality control measure in a new hospital.
    Corey AL, Snyder S.
    J Pediatr Oncol Nurs; 2008 May 09; 25(4):208-12. PubMed ID: 18539908
    [Abstract] [Full Text] [Related]

  • 14. Antibacterial prophylaxis in patients with cancer and neutropenia.
    Pasqualotto AC, Rosa DD, Machado AL.
    N Engl J Med; 2006 Jan 05; 354(1):90-4; author reply 90-4. PubMed ID: 16395830
    [No Abstract] [Full Text] [Related]

  • 15. Economic issues: toward a cost-effective approach to the management of febrile neutropenia in Japan.
    Masaoka T.
    Clin Infect Dis; 2004 Jul 15; 39 Suppl 1():S68-9. PubMed ID: 15250026
    [Abstract] [Full Text] [Related]

  • 16. Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients.
    Mullen CA.
    Pediatr Infect Dis J; 2003 Dec 15; 22(12):1138-42. PubMed ID: 14688588
    [Abstract] [Full Text] [Related]

  • 17. Pseudomonas aeruginosa pneumonia as a presenting entity in an AIDS patient.
    Kowal-Vern A, McFadden J.
    Clin Pediatr (Phila); 1989 Sep 15; 28(9):403. PubMed ID: 2504528
    [No Abstract] [Full Text] [Related]

  • 18. Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli.
    Gomez L, Garau J, Estrada C, Marquez M, Dalmau D, Xercavins M, Martí JM, Estany C.
    Cancer; 2003 Jan 15; 97(2):419-24. PubMed ID: 12518366
    [Abstract] [Full Text] [Related]

  • 19. Antibacterial prophylaxis in patients with cancer and neutropenia.
    Castagna L, Santoro A.
    N Engl J Med; 2006 Jan 05; 354(1):90-4; author reply 90-4. PubMed ID: 16395831
    [No Abstract] [Full Text] [Related]

  • 20. Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study.
    El-Mahallawy H, Sidhom I, El-Din NH, Zamzam M, El-Lamie MM.
    Int J Infect Dis; 2005 Jan 05; 9(1):43-51. PubMed ID: 15603994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.